Global and United States Pulmonary Surfactant Market Insights, Forecast to 2027

Global and United States Pulmonary Surfactant Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Pulmonary Surfactant Product Introduction
1.2 Market by Type
1.2.1 Global Pulmonary Surfactant Market Size Growth Rate by Type
1.2.2 Synthetic Pulmonary Surfactants
1.2.3 Animal Derived Surfactants
1.3 Market by Application
1.3.1 Global Pulmonary Surfactant Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pulmonary Surfactant Market Size, Estimates and Forecasts
2.1.1 Global Pulmonary Surfactant Revenue 2016-2027
2.1.2 Global Pulmonary Surfactant Sales 2016-2027
2.2 Global Pulmonary Surfactant, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pulmonary Surfactant Historical Market Size by Region (2016-2021)
2.3.1 Global Pulmonary Surfactant Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pulmonary Surfactant Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pulmonary Surfactant Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pulmonary Surfactant Sales Forecast by Region (2022-2027)
2.4.2 Global Pulmonary Surfactant Revenue Forecast by Region (2022-2027)
3 Global Pulmonary Surfactant Competitor Landscape by Players
3.1 Global Top Pulmonary Surfactant Manufacturers by Sales
3.1.1 Global Pulmonary Surfactant Sales by Manufacturer (2016-2021)
3.1.2 Global Pulmonary Surfactant Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pulmonary Surfactant Manufacturers by Revenue
3.2.1 Key Pulmonary Surfactant Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pulmonary Surfactant Revenue by Manufacturers (2016-2021)
3.2.3 Global Pulmonary Surfactant Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pulmonary Surfactant Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pulmonary Surfactant Revenue in 2020
3.2.6 Global Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pulmonary Surfactant Price by Manufacturers
3.4 Global Pulmonary Surfactant Manufacturing Base Distribution, Product Types
3.4.1 Pulmonary Surfactant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pulmonary Surfactant Product Type
3.4.3 Date of International Manufacturers Enter into Pulmonary Surfactant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pulmonary Surfactant Market Size by Type (2016-2021)
4.1.1 Global Pulmonary Surfactant Sales by Type (2016-2021)
4.1.2 Global Pulmonary Surfactant Revenue by Type (2016-2021)
4.1.3 Pulmonary Surfactant Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pulmonary Surfactant Market Size Forecast by Type (2022-2027)
4.2.1 Global Pulmonary Surfactant Sales Forecast by Type (2022-2027)
4.2.2 Global Pulmonary Surfactant Revenue Forecast by Type (2022-2027)
4.2.3 Pulmonary Surfactant Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pulmonary Surfactant Market Size by Application (2016-2021)
5.1.1 Global Pulmonary Surfactant Sales by Application (2016-2021)
5.1.2 Global Pulmonary Surfactant Revenue by Application (2016-2021)
5.1.3 Pulmonary Surfactant Price by Application (2016-2021)
5.2 Pulmonary Surfactant Market Size Forecast by Application (2022-2027)
5.2.1 Global Pulmonary Surfactant Sales Forecast by Application (2022-2027)
5.2.2 Global Pulmonary Surfactant Revenue Forecast by Application (2022-2027)
5.2.3 Global Pulmonary Surfactant Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Pulmonary Surfactant Market Size YoY Growth 2016-2027
6.1.1 United States Pulmonary Surfactant Sales YoY Growth 2016-2027
6.1.2 United States Pulmonary Surfactant Revenue YoY Growth 2016-2027
6.1.3 United States Pulmonary Surfactant Market Share in Global Market 2016-2027
6.2 United States Pulmonary Surfactant Market Size by Players (International and Local Players)
6.2.1 United States Top Pulmonary Surfactant Players by Sales (2016-2021)
6.2.2 United States Top Pulmonary Surfactant Players by Revenue (2016-2021)
6.3 United States Pulmonary Surfactant Historic Market Review by Type (2016-2021)
6.3.1 United States Pulmonary Surfactant Sales Market Share by Type (2016-2021)
6.3.2 United States Pulmonary Surfactant Revenue Market Share by Type (2016-2021)
6.3.3 United States Pulmonary Surfactant Price by Type (2016-2021)
6.4 United States Pulmonary Surfactant Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Pulmonary Surfactant Sales Forecast by Type (2022-2027)
6.4.2 United States Pulmonary Surfactant Revenue Forecast by Type (2022-2027)
6.4.3 United States Pulmonary Surfactant Price Forecast by Type (2022-2027)
6.5 United States Pulmonary Surfactant Historic Market Review by Application (2016-2021)
6.5.1 United States Pulmonary Surfactant Sales Market Share by Application (2016-2021)
6.5.2 United States Pulmonary Surfactant Revenue Market Share by Application (2016-2021)
6.5.3 United States Pulmonary Surfactant Price by Application (2016-2021)
6.6 United States Pulmonary Surfactant Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Pulmonary Surfactant Sales Forecast by Application (2022-2027)
6.6.2 United States Pulmonary Surfactant Revenue Forecast by Application (2022-2027)
6.6.3 United States Pulmonary Surfactant Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pulmonary Surfactant Market Size YoY Growth 2016-2027
7.2 North America Pulmonary Surfactant Market Facts & Figures by Country
7.2.1 North America Pulmonary Surfactant Sales by Country (2016-2021)
7.2.2 North America Pulmonary Surfactant Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pulmonary Surfactant Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pulmonary Surfactant Market Facts & Figures by Region
8.2.1 Asia Pacific Pulmonary Surfactant Sales by Region (2016-2021)
8.2.2 Asia Pacific Pulmonary Surfactant Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Pulmonary Surfactant Market Size YoY Growth 2016-2027
9.2 Europe Pulmonary Surfactant Market Facts & Figures by Country
9.2.1 Europe Pulmonary Surfactant Sales by Country (2016-2021)
9.2.2 Europe Pulmonary Surfactant Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pulmonary Surfactant Market Size YoY Growth 2016-2027
10.2 Latin America Pulmonary Surfactant Market Facts & Figures by Country
10.2.1 Latin America Pulmonary Surfactant Sales by Country (2016-2021)
10.2.2 Latin America Pulmonary Surfactant Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pulmonary Surfactant Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pulmonary Surfactant Market Facts & Figures by Country
11.2.1 Middle East and Africa Pulmonary Surfactant Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pulmonary Surfactant Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Description and Business Overview
12.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim Pulmonary Surfactant Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 AbbVie
12.2.1 AbbVie Corporation Information
12.2.2 AbbVie Description and Business Overview
12.2.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AbbVie Pulmonary Surfactant Products Offered
12.2.5 AbbVie Recent Development
12.3 Lyomark Pharma
12.3.1 Lyomark Pharma Corporation Information
12.3.2 Lyomark Pharma Description and Business Overview
12.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Lyomark Pharma Pulmonary Surfactant Products Offered
12.3.5 Lyomark Pharma Recent Development
12.4 Tekzima (Noargen)
12.4.1 Tekzima (Noargen) Corporation Information
12.4.2 Tekzima (Noargen) Description and Business Overview
12.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tekzima (Noargen) Pulmonary Surfactant Products Offered
12.4.5 Tekzima (Noargen) Recent Development
12.5 ONY Biotech
12.5.1 ONY Biotech Corporation Information
12.5.2 ONY Biotech Description and Business Overview
12.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ONY Biotech Pulmonary Surfactant Products Offered
12.5.5 ONY Biotech Recent Development
12.6 Abbott
12.6.1 Abbott Corporation Information
12.6.2 Abbott Description and Business Overview
12.6.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abbott Pulmonary Surfactant Products Offered
12.6.5 Abbott Recent Development
12.7 Aviva Systems Biology
12.7.1 Aviva Systems Biology Corporation Information
12.7.2 Aviva Systems Biology Description and Business Overview
12.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Aviva Systems Biology Pulmonary Surfactant Products Offered
12.7.5 Aviva Systems Biology Recent Development
12.8 LSBio
12.8.1 LSBio Corporation Information
12.8.2 LSBio Description and Business Overview
12.8.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.8.4 LSBio Pulmonary Surfactant Products Offered
12.8.5 LSBio Recent Development
12.9 Biomatik
12.9.1 Biomatik Corporation Information
12.9.2 Biomatik Description and Business Overview
12.9.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biomatik Pulmonary Surfactant Products Offered
12.9.5 Biomatik Recent Development
12.10 Biorbyt
12.10.1 Biorbyt Corporation Information
12.10.2 Biorbyt Description and Business Overview
12.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Biorbyt Pulmonary Surfactant Products Offered
12.10.5 Biorbyt Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Description and Business Overview
12.11.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim Pulmonary Surfactant Products Offered
12.11.5 Boehringer Ingelheim Recent Development
12.12 XpressBio
12.12.1 XpressBio Corporation Information
12.12.2 XpressBio Description and Business Overview
12.12.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.12.4 XpressBio Products Offered
12.12.5 XpressBio Recent Development
12.13 Creative Diagnostics
12.13.1 Creative Diagnostics Corporation Information
12.13.2 Creative Diagnostics Description and Business Overview
12.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Creative Diagnostics Products Offered
12.13.5 Creative Diagnostics Recent Development
12.14 Nanjing Norris Pharm Technology
12.14.1 Nanjing Norris Pharm Technology Corporation Information
12.14.2 Nanjing Norris Pharm Technology Description and Business Overview
12.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Nanjing Norris Pharm Technology Products Offered
12.14.5 Nanjing Norris Pharm Technology Recent Development
12.15 Windtree Therapeutics
12.15.1 Windtree Therapeutics Corporation Information
12.15.2 Windtree Therapeutics Description and Business Overview
12.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Windtree Therapeutics Products Offered
12.15.5 Windtree Therapeutics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pulmonary Surfactant Industry Trends
13.2 Pulmonary Surfactant Market Drivers
13.3 Pulmonary Surfactant Market Challenges
13.4 Pulmonary Surfactant Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pulmonary Surfactant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Pulmonary Surfactant Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Synthetic Pulmonary Surfactants
Table 3. Major Manufacturers of Animal Derived Surfactants
Table 4. Global Pulmonary Surfactant Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Pulmonary Surfactant Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Pulmonary Surfactant Sales by Regions (2016-2021) & (K Units)
Table 7. Global Pulmonary Surfactant Sales Market Share by Regions (2016-2021)
Table 8. Global Pulmonary Surfactant Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Pulmonary Surfactant Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Pulmonary Surfactant Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Pulmonary Surfactant Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Pulmonary Surfactant Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Pulmonary Surfactant Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Pulmonary Surfactant Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Pulmonary Surfactant Manufacturers by Revenue (US$ Million) in 2020
Table 16. Pulmonary Surfactant Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Pulmonary Surfactant Revenue Share by Manufacturers (2016-2021)
Table 18. Global Pulmonary Surfactant Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Surfactant as of 2020)
Table 20. Key Manufacturers Pulmonary Surfactant Price (2016-2021) (USD/Unit)
Table 21. Pulmonary Surfactant Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pulmonary Surfactant Product Type
Table 23. Date of International Manufacturers Enter into Pulmonary Surfactant Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pulmonary Surfactant Sales by Type (2016-2021) (K Units)
Table 26. Global Pulmonary Surfactant Sales Share by Type (2016-2021)
Table 27. Global Pulmonary Surfactant Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Pulmonary Surfactant Revenue Share by Type (2016-2021)
Table 29. Pulmonary Surfactant Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Pulmonary Surfactant Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Pulmonary Surfactant Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Pulmonary Surfactant Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Pulmonary Surfactant Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Pulmonary Surfactant Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Pulmonary Surfactant Sales by Application (2016-2021) (K Units)
Table 36. Global Pulmonary Surfactant Sales Share by Application (2016-2021)
Table 37. Global Pulmonary Surfactant Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Pulmonary Surfactant Revenue Share by Application (2016-2021)
Table 39. Pulmonary Surfactant Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Pulmonary Surfactant Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Pulmonary Surfactant Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Pulmonary Surfactant Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Pulmonary Surfactant Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Pulmonary Surfactant Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. United States Pulmonary Surfactant Sales (K Units) of Key Companies (2016-2021)
Table 46. United States Pulmonary Surfactant Sales Share by Company (2016-2021)
Table 47. United States Pulmonary Surfactant Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Pulmonary Surfactant Revenue Share by Company (2016-2021)
Table 49. United States Pulmonary Surfactant Sales (K Units) by Type (2016-2021)
Table 50. United States Pulmonary Surfactant Sales Share by Type (2016-2021)
Table 51. United States Pulmonary Surfactant Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Pulmonary Surfactant Price (USD/Unit) by Type (2016-2021)
Table 53. United States Pulmonary Surfactant Sales (K Units) by Type (2022-2027)
Table 54. United States Pulmonary Surfactant Sales Share by Type (2022-2027)
Table 55. United States Pulmonary Surfactant Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Pulmonary Surfactant Revenue Share by Type (2022-2027)
Table 57. United States Pulmonary Surfactant Price (USD/Unit) by Type (2022-2027)
Table 58. United States Pulmonary Surfactant Sales (K Units) by Application (2016-2021)
Table 59. United States Pulmonary Surfactant Sales Share by Application (2016-2021)
Table 60. United States Pulmonary Surfactant Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Pulmonary Surfactant Price (USD/Unit) by Application (2016-2021)
Table 62. United States Pulmonary Surfactant Sales (K Units) by Application (2022-2027)
Table 63. United States Pulmonary Surfactant Sales Share by Application (2022-2027)
Table 64. United States Pulmonary Surfactant Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Pulmonary Surfactant Revenue Share by Application (2022-2027)
Table 66. United States Pulmonary Surfactant Price (USD/Unit) by Application (2022-2027)
Table 67. North America Pulmonary Surfactant Sales by Country (2016-2021) & (K Units)
Table 68. North America Pulmonary Surfactant Sales Market Share by Country (2016-2021)
Table 69. North America Pulmonary Surfactant Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Pulmonary Surfactant Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Pulmonary Surfactant Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Pulmonary Surfactant Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Pulmonary Surfactant Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Pulmonary Surfactant Revenue Market Share by Region (2016-2021)
Table 75. Europe Pulmonary Surfactant Sales by Country (2016-2021) & (K Units)
Table 76. Europe Pulmonary Surfactant Sales Market Share by Country (2016-2021)
Table 77. Europe Pulmonary Surfactant Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Pulmonary Surfactant Revenue Market Share by Country (2016-2021)
Table 79. Latin America Pulmonary Surfactant Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Pulmonary Surfactant Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Pulmonary Surfactant Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Pulmonary Surfactant Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Pulmonary Surfactant Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Pulmonary Surfactant Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Pulmonary Surfactant Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Pulmonary Surfactant Revenue Market Share by Country (2016-2021)
Table 87. Boehringer Ingelheim Corporation Information
Table 88. Boehringer Ingelheim Description and Business Overview
Table 89. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Boehringer Ingelheim Pulmonary Surfactant Product
Table 91. Boehringer Ingelheim Recent Development
Table 92. AbbVie Corporation Information
Table 93. AbbVie Description and Business Overview
Table 94. AbbVie Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. AbbVie Product
Table 96. AbbVie Recent Development
Table 97. Lyomark Pharma Corporation Information
Table 98. Lyomark Pharma Description and Business Overview
Table 99. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Lyomark Pharma Product
Table 101. Lyomark Pharma Recent Development
Table 102. Tekzima (Noargen) Corporation Information
Table 103. Tekzima (Noargen) Description and Business Overview
Table 104. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Tekzima (Noargen) Product
Table 106. Tekzima (Noargen) Recent Development
Table 107. ONY Biotech Corporation Information
Table 108. ONY Biotech Description and Business Overview
Table 109. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. ONY Biotech Product
Table 111. ONY Biotech Recent Development
Table 112. Abbott Corporation Information
Table 113. Abbott Description and Business Overview
Table 114. Abbott Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Abbott Product
Table 116. Abbott Recent Development
Table 117. Aviva Systems Biology Corporation Information
Table 118. Aviva Systems Biology Description and Business Overview
Table 119. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Aviva Systems Biology Product
Table 121. Aviva Systems Biology Recent Development
Table 122. LSBio Corporation Information
Table 123. LSBio Description and Business Overview
Table 124. LSBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. LSBio Product
Table 126. LSBio Recent Development
Table 127. Biomatik Corporation Information
Table 128. Biomatik Description and Business Overview
Table 129. Biomatik Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Biomatik Product
Table 131. Biomatik Recent Development
Table 132. Biorbyt Corporation Information
Table 133. Biorbyt Description and Business Overview
Table 134. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Biorbyt Product
Table 136. Biorbyt Recent Development
Table 137. Reddot Biotech Corporation Information
Table 138. Reddot Biotech Description and Business Overview
Table 139. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Reddot Biotech Product
Table 141. Reddot Biotech Recent Development
Table 142. XpressBio Corporation Information
Table 143. XpressBio Description and Business Overview
Table 144. XpressBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. XpressBio Product
Table 146. XpressBio Recent Development
Table 147. Creative Diagnostics Corporation Information
Table 148. Creative Diagnostics Description and Business Overview
Table 149. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Creative Diagnostics Product
Table 151. Creative Diagnostics Recent Development
Table 152. Nanjing Norris Pharm Technology Corporation Information
Table 153. Nanjing Norris Pharm Technology Description and Business Overview
Table 154. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Nanjing Norris Pharm Technology Product
Table 156. Nanjing Norris Pharm Technology Recent Development
Table 157. Windtree Therapeutics Corporation Information
Table 158. Windtree Therapeutics Description and Business Overview
Table 159. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Windtree Therapeutics Product
Table 161. Windtree Therapeutics Recent Development
Table 162. Pulmonary Surfactant Market Trends
Table 163. Pulmonary Surfactant Market Drivers
Table 164. Pulmonary Surfactant Market Challenges
Table 165. Pulmonary Surfactant Market Restraints
Table 166. Pulmonary Surfactant Customers List
Table 167. Pulmonary Surfactant Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Surfactant Product Picture
Figure 2. Global Pulmonary Surfactant Sales Market Share by Type in 2020 & 2027
Figure 3. Synthetic Pulmonary Surfactants Product Picture
Figure 4. Animal Derived Surfactants Product Picture
Figure 5. Global Pulmonary Surfactant Sales Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. laboratory
Figure 8. Others
Figure 9. Pulmonary Surfactant Report Years Considered
Figure 10. Global Pulmonary Surfactant Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pulmonary Surfactant Market Size 2016-2027 (US$ Million)
Figure 12. Global Pulmonary Surfactant Sales 2016-2027 (K Units)
Figure 13. Global Pulmonary Surfactant Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Pulmonary Surfactant Sales Market Share by Region (2016-2021)
Figure 15. Global Pulmonary Surfactant Sales Market Share by Region in 2020
Figure 16. Global Pulmonary Surfactant Revenue Market Share by Region (2016-2021)
Figure 17. Global Pulmonary Surfactant Revenue Market Share by Region in 2020
Figure 18. Global Pulmonary Surfactant Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Pulmonary Surfactant Revenue in 2020
Figure 20. Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Pulmonary Surfactant Sales Market Share by Type (2016-2021)
Figure 22. Global Pulmonary Surfactant Sales Market Share by Type in 2020
Figure 23. Global Pulmonary Surfactant Revenue Market Share by Type (2016-2021)
Figure 24. Global Pulmonary Surfactant Revenue Market Share by Type in 2020
Figure 25. Global Pulmonary Surfactant Sales Market Share by Application (2016-2021)
Figure 26. Global Pulmonary Surfactant Sales Market Share by Application in 2020
Figure 27. Global Pulmonary Surfactant Revenue Market Share by Application (2016-2021)
Figure 28. Global Pulmonary Surfactant Revenue Market Share by Application in 2020
Figure 29. United States Pulmonary Surfactant Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States Pulmonary Surfactant Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Pulmonary Surfactant Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Pulmonary Surfactant Players Market Share by Revenue in Pulmonary Surfactant in 2020
Figure 33. United States Pulmonary Surfactant Revenue Share by Type (2016-2021)
Figure 34. United States Pulmonary Surfactant Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Pulmonary Surfactant Revenue Share by Application (2016-2021)
Figure 36. United States Pulmonary Surfactant Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Pulmonary Surfactant Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Pulmonary Surfactant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Pulmonary Surfactant Sales Market Share by Country in 2020
Figure 40. North America Pulmonary Surfactant Revenue Market Share by Country in 2020
Figure 41. U.S. Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Pulmonary Surfactant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Pulmonary Surfactant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Pulmonary Surfactant Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Pulmonary Surfactant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Pulmonary Surfactant Sales Market Share by Country in 2020
Figure 48. Europe Pulmonary Surfactant Revenue Market Share by Country in 2020
Figure 49. Germany Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Pulmonary Surfactant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Pulmonary Surfactant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Pulmonary Surfactant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Pulmonary Surfactant Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Pulmonary Surfactant Revenue Growth Rate (2016-2021

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs